Sign in

    Francis S. Soistman

    Chief Executive Officer at eHealth Inc
    Board
    Since November 2021
    Age
    67 years
    Education
    Holds a B.S. in accounting and finance from Towson University and is a graduate of the Stanford University executive program.
    Tenure
    Joined EHTH in November 2021 as Chief Executive Officer and a member of the Board of Directors.

    Also at eHealth Inc

    GGG
    Gavin G. Galimi
    **Senior Vice President, General Counsel, and Corporate Secretary**
    JJS
    John J. Stelben
    Senior Vice President and Chief Financial Officer (CFO)
    MMB
    Michelle M. Barbeau
    Chief Revenue Officer

    About

    Francis S. Soistman serves as Chief Executive Officer and a member of the Board of Directors at eHealth, Inc. since November 2021.

    He brings nearly four decades of experience in healthcare and managed care, where his roles have centered on driving operational improvements and financial turnarounds.

    Before joining eHealth, Inc., he founded and led Healthcare Management and Transformation Advisory Services LLC and held significant leadership roles at CVS Health, Aetna, and other prominent healthcare organizations.

    His career reflects a commitment to advancing healthcare through strategic leadership and operational expertise, positioning him as a key figure in the industry.

    $EHTH Performance Under Francis S. Soistman

    Past Roles

    OrganizationRoleDate RangeDetails
    Healthcare Management and Transformation Advisory Services LLC Founder and President January 2020 - November 2021 Advisory services company in the healthcare space
    CVS Health Executive Vice President January 2013 - September 2019 Held executive leadership roles; concurrently involved with Aetna
    Aetna President of Government Services N/A Oversaw government services in managed care
    Jessamine Healthcare Co-Founder N/A Co-founded the company
    Coventry Healthcare Executive Leadership N/A Held executive leadership role
    Principal Health Care Executive Leadership N/A Held executive leadership role
    Blue Cross Blue Shield of Maryland Executive Leadership N/A Held executive leadership role

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Salary$750,000 Annual (2023)Base salary for 2023; remained unchanged from 2022
    Stock Awards$2,990,000 Grant Date: April 10, 2023Includes equity awards: RSUs of 187,500 shares with a grant date fair value of $1,725,000 and two PSU tranches with grant date fair values of $575,000 and $690,000; details include thresholds and targets (PSU 1: Threshold: 31,250, Target: 62,500, Maximum: 62,500; PSU 2: Threshold: 37,500, Target: 75,000, Maximum: 75,000)
    All Other Compensation$16,758 2023401(k) Plan Contributions: $9,900; Group Term Life Insurance: $6,858

    Performance Compensation

    Data from  FY 2023

    Adjusted EBITDA Performance

    MetricInfo
    Threshold($15.0M)
    Maximum (Cap)$15.0M
    Weighting60%
    Target Maximum Weighted Payout120%
    2023 Results$14.06M
    2023 Actual Payout Curve195%
    Weighted Payout Prior to Adjustment117%

    Revenue Performance

    MetricInfo
    Threshold$420.0M
    Maximum (Cap)$440.0M
    Weighting20%
    Target Maximum Weighted Payout30%
    2023 Results$452.9M
    2023 Actual Payout Curve150%
    Weighted Payout Prior to Adjustment30%

    FY23 Priorities

    MetricInfo
    Threshold2 of 4 goals met
    Maximum (Cap)4 of 4 goals met
    Weighting20%
    Target Maximum Weighted Payout30%
    2023 Results3 of 4 goals met
    2023 Actual Payout Curve100%
    Weighted Payout Prior to Adjustment20%

    Additional Performance Compensation Details

    • Bonus Payout: Francis S. Soistman received a 165% payout of his base salary resulting in an actual bonus of $1,237,500 for 2023.
    • Payout Cap & Vesting: The maximum payout under the 2023 Bonus Program was capped at 180% of the target; however, a reduction via negative discretion set the payout at 150%.
    • Evaluation & Vesting Period: The performance period evaluated corporate goals tied to Adjusted EBITDA, Revenue, and FY23 Priorities for 2023.
    • Grant Details for Equity Awards: Grant Date was April 10, 2023 with an approval date of March 27, 2023; grant date fair values were $575,000 for one PSU tranche and $690,000 for the other, alongside RSUs.
    • Grant Date Stock Price: The closing market price was $8.72 as of December 31, 2023.